Dyadic Newsroom

Dyadic International Analyst Ratings

BenzingaJul 8 06:25 ET

Dyadic International: A Buy Rating on Strong Partnership Prospects and Revenue Growth Potential

TipRanksJul 8 06:18 ET

Analysts' Top Healthcare Picks: Anavex Life Sciences (AVXL), Dyadic International (DYAI)

TipRanksNov 21, 2023 06:40 ET

HC Wainwright & Co. Reiterates Buy on Dyadic International, Maintains $6 Price Target

BenzingaNov 13, 2023 07:50 ET

Dyadic International Analyst Ratings

BenzingaNov 13, 2023 07:49 ET

Dyadic International's Growth Prospects Bolstered by Vaccine Development Collaboration: A Buy Rating Reaffirmed

TipRanksOct 23, 2023 06:25 ET

HC Wainwright & Co. Reiterates Buy on Dyadic International, Maintains $6 Price Target

BenzingaMay 24, 2023 06:41 ET

H.C. Wainwright Keeps Their Buy Rating on Dyadic International (DYAI)

TipRanksMay 24, 2023 06:25 ET

Analysts Offer Insights on Healthcare Companies: Dyadic International (DYAI), Biophytis (BPTS) and 2seventy Bio (TSVT)

TipRanksFeb 3, 2023 06:35 ET

Dyadic International Analyst Ratings

Benzinga Analyst RatingsFeb 3, 2023 06:13 ET

HC Wainwright & Co. Reiterates Buy on Dyadic International, Maintains $6 Price Target

Benzinga Real-time NewsFeb 3, 2023 06:13 ET

Analysts Offer Insights on Healthcare Companies: Satsuma Pharmaceuticals (STSA) and Dyadic International (DYAI)

TipRanksNov 14, 2022 09:55 ET

Dyadic Intl Cut to Neutral From Buy by Dawson James

Dow JonesJul 18, 2022 10:53 ET

Dyadic International analyst ratings

Benzinga Analyst RatingsJul 18, 2022 10:44 ET